CV Sciences Files 8-K on Financials
Ticker: CVSI · Form: 8-K · Filed: Mar 28, 2024 · CIK: 1510964
| Field | Detail |
|---|---|
| Company | Cv Sciences, Inc. (CVSI) |
| Form Type | 8-K |
| Filed Date | Mar 28, 2024 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 3 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, sec-filing
Related Tickers: CVSI
TL;DR
CV Sciences dropped an 8-K on financials - check it for the latest numbers.
AI Summary
CV Sciences, Inc. filed an 8-K on March 28, 2024, to report on its results of operations and financial condition, as well as to provide Regulation FD disclosures and file financial statements and exhibits. The filing does not contain specific financial figures or operational details within the provided text.
Why It Matters
This filing indicates that CV Sciences is providing updates on its financial performance and operational status to the SEC, which is important for investors to monitor the company's health.
Risk Assessment
Risk Level: low — The filing is a standard disclosure of financial information and does not inherently present new risks.
Key Players & Entities
- CV Sciences, Inc. (company) — Registrant
- 0000950170-24-037652 (filing_id) — Accession Number
- March 28, 2024 (date) — Report Date
- San Diego, California (location) — Principal Executive Offices
FAQ
What specific financial results are being reported in this 8-K?
The provided text states the filing is for 'Results of Operations and Financial Condition' but does not include the specific financial figures.
What is the purpose of the Regulation FD Disclosure mentioned in the filing?
Regulation FD (Fair Disclosure) ensures that material non-public information is disclosed to all investors simultaneously.
When was CV Sciences, Inc. incorporated and in which state?
CV Sciences, Inc. was incorporated in Delaware.
What is the IRS Employer Identification Number for CV Sciences, Inc.?
The IRS Employer Identification Number for CV Sciences, Inc. is 80-0944970.
What were the former names of CV Sciences, Inc. and when did the name changes occur?
CV Sciences, Inc. was formerly known as CannaVEST Corp. (name change on 20130205) and Foreclosure Solutions, Inc. (name change on 20110124).
Filing Stats: 771 words · 3 min read · ~3 pages · Grade level 12.2 · Accepted 2024-03-28 09:20:52
Filing Documents
- cvsi-20240328.htm (8-K) — 44KB
- cvsi-ex99_1.htm (EX-99.1) — 399KB
- 0000950170-24-037652.txt ( ) — 564KB
- cvsi-20240328.xsd (EX-101.SCH) — 22KB
- cvsi-20240328_htm.xml (XML) — 4KB
02 Results of Operations and Financial Conditions
Item 2.02 Results of Operations and Financial Conditions The information provided below in "Item 7.01 - Regulation FD Disclosure" of this Current Report on Form 8-K is incorporated by reference into this Item 2.02.
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure On March 28, 2024, CV Sciences, Inc. (the "Company") issued a press release regarding the Company's financial results for its fiscal year and quarter ended December 31, 2023. A copy of that press release is furnished as Exhibit 99.1 hereto and incorporated herein by reference.The press release includes non-GAAP financial measures as defined in Regulation G. The press release also includes a presentation of the most directly comparable financial measures calculated and presented in accordance with accounting principles generally accepted in the United States (GAAP), information reconciling the non-GAAP financial measures to the GAAP financial measures and a discussion of the reasons why the Company's management believes that presentation of the non-GAAP financial measures provides useful information to investors regarding the Company's financial condition and results of operations. The non-GAAP financial measures presented therein should be considered in addition to, not as a substitute for, or superior to, financial measures calculated and presented in accordance with GAAP. Exhibit 99.1 contains forward-looking statements. These forward-looking statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Forward-looking statements are based upon assumptions as to future events that may not prove to be accurate. Actual outcomes and results may differ materially from what is expressed in these forward-looking statements. The information set forth under Item 7.01 of this Current Report on Form 8-K ("Current Report"), including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of such section. The information in Item 7.01 of this Current Report, including Exhibit 99.1, shall not be incorporat
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits (d) Exhibits Exhibit Number Description 99.1 Press Release of CV Sciences, Inc. dated March 28, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) * Filed herewith. 1
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CV SCIENCES, INC. Date: March 28, 2024 By: /s/ Joseph Dowling Joseph Dowling Chief Executive Officer 2